Mangoceuticals files lawsuit seeking >$73M against Clarity Ventures; CEO options repriced to $0.45

MANGOCEUTICALS, INC.

Filed lawsuit in Texas state court against Clarity Ventures seeking damages exceeding $73M for failure to deliver HIPAA-compliant ERP/eCommerce platform.
Clarity denies allegations and asserts counterclaims for unpaid invoices; company states all binding payments were made in full.
CEO Jacob Cohen's options repriced: 50,000 at $16.50, 83,333 at $4.80, 2,000,000 at $2.30 → new exercise price $0.45 per share effective March 16, 2026.
Company independently developed and deployed a new proprietary telehealth platform that does not rely on Clarity’s technology.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.